Body Modifications

Background
Body Modifications, or BM's, are a technology owned and practiced by CoPharma, GmbH. The technology was pioneered by FSol, LLC before the company's purchase by CoPharma. The technology was invented as a means to synthesize food, and works by using several solutions and closed environments to catalyze the rapid growth of various animal tissues, specifically muscle and fat tissue. The technology was mastered on meats from chicken, cattle, and pig before FSol was acquired. CoPharma was able to take the technology and apply it not only to human tissue, but also to a living subject.

Procedure
Subjects of the treatment are placed under anesthetic for the full time of the operation, which can vary from 1 to 5 hours, depending on the desired area. The area is surgically opened, and enclosed with a small chamber that simulates the proper environment for the cell growth/decay. The proper solution is administered inside of this chamber, and operators monitor the process, stepping in only for proper shaping or adjustments.

Other Operations
BM's were initially created for the purpose of simple cell growth and decay, but CoPharma had also found auxiliary uses for the solutions themselves. The solutions, when administered orally, could have similar, but lessened effects than the operation provides. This opened up a new window for the company in BM's, as the scope of the project increased significantly. Solutions could now be used in replacement of growth hormones in children. However, the effects of this type of procedure grew to be unpredictable, and CoPharma has been recently put under fire for unexpected side effects (see: Miku).